Yuji Nimura Selected Research

Enteral Nutrition (Feeding, Tube)

11/2006	Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial.
4/2005	Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Nimura Research Topics

Disease

49	Neoplasms (Cancer) 01/2014 - 01/2002
24	Carcinoma (Carcinomatosis) 02/2010 - 01/2002
15	Cholangiocarcinoma 08/2015 - 06/2003
11	Neoplasm Metastasis (Metastasis) 08/2015 - 01/2005
10	Klatskin Tumor 04/2011 - 12/2002
9	Liver Failure 05/2011 - 10/2002
7	Cholangitis 01/2007 - 07/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 05/2012 - 10/2002
5	Cholecystitis 01/2012 - 01/2007
5	Acute Cholecystitis 01/2007 - 01/2007
5	Hepatocellular Carcinoma (Hepatoma) 03/2006 - 12/2002
4	Adenocarcinoma 05/2012 - 02/2006
4	Hemorrhage 08/2011 - 01/2007
4	Hyperbilirubinemia 05/2011 - 08/2003
4	Infections 01/2007 - 09/2003
4	Ischemia 01/2007 - 06/2004
4	Liver Neoplasms (Liver Cancer) 03/2006 - 12/2002
4	Cholestasis 08/2004 - 12/2002
3	Lymphatic Metastasis 07/2013 - 01/2006
3	Peritonitis 05/2011 - 01/2007
3	Colorectal Neoplasms (Colorectal Cancer) 03/2011 - 06/2003
3	Bone Resorption 02/2009 - 12/2006
3	Breast Neoplasms (Breast Cancer) 01/2009 - 07/2002
3	Peptic Esophagitis (Reflux Esophagitis) 01/2009 - 05/2005
3	Gastroesophageal Reflux (GERD) 01/2009 - 09/2003
3	Inflammation (Inflammations) 01/2007 - 01/2007
3	Endotoxemia 01/2007 - 08/2005
3	Obstructive Jaundice (Cholestatic Jaundice) 10/2004 - 07/2002
2	Margins of Excision 12/2013 - 01/2006
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2012 - 12/2002
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2012 - 03/2006
2	Esophageal Neoplasms (Esophageal Cancer) 02/2010 - 05/2005
2	Cholecystolithiasis 09/2009 - 09/2003
2	Carcinoma in Situ 09/2009 - 12/2004
2	Osteoporosis 02/2009 - 06/2007
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2009 - 01/2007
2	Lung Neoplasms (Lung Cancer) 09/2008 - 06/2004
2	Carcinogenesis 11/2007 - 02/2006
2	Digestive System Diseases 01/2007 - 07/2003
2	Fever (Fevers) 01/2007 - 07/2002
2	Sepsis (Septicemia) 01/2007 - 07/2002
2	Wounds and Injuries (Trauma) 01/2007 - 01/2003
2	Stomach Neoplasms (Stomach Cancer) 07/2006 - 01/2004
2	Hemorrhagic Shock 09/2005 - 08/2005
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2005 - 08/2005
2	Bacterial Infections (Bacterial Infection) 08/2004 - 12/2002
2	Metaplasia 05/2004 - 05/2002
2	Choledocholithiasis 11/2003 - 09/2003
2	Calculi (Calculus) 07/2003 - 01/2003
2	Septic Shock (Toxic Shock Syndrome) 05/2003 - 01/2002

Drug/Important Bio-Agent (IBA)

7	BilirubinIBA 05/2011 - 01/2003
7	MucinsIBA 02/2006 - 05/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 05/2003
4	Small Interfering RNA (siRNA)IBA 02/2010 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 02/2006 - 07/2003
3	BismuthIBA 04/2011 - 12/2007
3	AcidsIBA 01/2009 - 09/2003
3	Ethanol (Ethyl Alcohol)IBA 01/2008 - 11/2003
3	Bile Pigments (Bilin)IBA 11/2007 - 04/2005
3	LigandsIBA 07/2006 - 09/2003
2	Indicators and Reagents (Reagents)IBA 07/2013 - 05/2003
2	Polycomb-Group ProteinsIBA 02/2010 - 09/2009
2	Cadherins (E-Cadherin)IBA 02/2010 - 11/2007
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2009 - 02/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2009 - 10/2007
2	MicroRNAs (MicroRNA)IBA 09/2008 - 06/2004
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2008 - 03/2006
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2007 - 12/2006
2	CytokinesIBA 06/2007 - 08/2004
2	salicylhydroxamic acid (SHAM)IBA 01/2007 - 08/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007 - 08/2002
2	Biomarkers (Surrogate Marker)IBA 12/2006 - 07/2006
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2006 - 04/2005
2	Monoclonal AntibodiesIBA 07/2006 - 02/2003
2	Cyclin D1IBA 04/2005 - 12/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2004 - 06/2002
2	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 04/2004 - 12/2002
2	CholesterolIBA 07/2003 - 01/2003

Therapy/Procedure

36	Hepatectomy 08/2015 - 01/2002
11	Pancreaticoduodenectomy 01/2014 - 08/2005
9	Therapeutics 05/2011 - 10/2002
7	Cholecystectomy 01/2007 - 07/2006
5	Lymph Node Excision (Lymph Node Dissection) 05/2012 - 12/2002
5	Gastrectomy 01/2009 - 09/2003
4	Drug Therapy (Chemotherapy) 08/2015 - 10/2002
4	Operative Surgical Procedures 01/2014 - 06/2003
4	Laparoscopic Cholecystectomy 01/2007 - 09/2003
3	Liver Transplantation 04/2011 - 12/2002
3	Gastroenterostomy 05/2008 - 09/2003
3	Resuscitation 01/2007 - 08/2005
3	Endoscopic Sphincterotomy 01/2007 - 09/2003
2	Laparotomy 08/2011 - 01/2002
2	Pancreatectomy 08/2007 - 01/2004
2	Colectomy 07/2007 - 01/2006
2	Critical Care (Surgical Intensive Care) 01/2007 - 01/2007
2	Ligation 01/2007 - 08/2004
2	Length of Stay 01/2007 - 01/2007
2	Contraindications 01/2007 - 01/2007
2	Enteral Nutrition (Feeding, Tube) 11/2006 - 04/2005
2	Esophagectomy 05/2005 - 04/2004